First-degree atrioventricular block is associated with advanced atrioventricular block, atrial fibrillation and left ventricular dysfunction in patients with hypertension

Journal of Hypertension

Volumn 32, Issue 5, 2014, Pages 1115-1120

  Uhm, Jae Sun ^a   Shim, Jaemin ^a   Wi, Jin ^a   Mun, Hee Sun ^a   Park, Junbeom ^a   Park, Sung Ha ^a   Joung, Boyoung ^a   Pak, Hui Nam ^a   Lee, Moon Hyoung ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

atrial fibrillation; atrioventricular block; left ventricular dysfunction; PR interval

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; FEMALE; FIRST DEGREE ATRIOVENTRICULAR BLOCK; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PR INTERVAL; PRIORITY JOURNAL; PROGNOSIS; SICK SINUS SYNDROME; ATRIAL FIBRILLATION; ATRIOVENTRICULAR BLOCK; COMPLICATION; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED;

ADULT; ATRIAL FIBRILLATION; ATRIOVENTRICULAR BLOCK; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84898038640     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000113     Document Type: Article

References (38)

1. Olgin J, Zipes DP. Specific arrhythmias: diagnosis and treatment. In: Braunwald E, editor. Braunwald's heart disease: a textbook of cardiovascular medicine. Philadelphia, PA: Elsevier Saunders; 2012. pp. 818-822.
2. Rijnbeek PR, Witsenburg M, Schrama E, Hess J, Kors JA. New normal limits for the paediatric electrocardiogram. Eur Heart J 2001; 22:702-711.
3. Uhm JS, Hwang IU, Oh YS, Choi MS, Jang SW, Shin WS, et al. Prevalence of electrocardiographic findings suggestive of sudden cardiac death risk in 10 867 apparently healthy young Korean men. Pacing Clinical Electrophysiol 2011; 34:717-723.
4. Johnson RL, Averill KH, Lamb LE. Electrocardiographic findings in 67 375 asymptomatic subjects. VII. Atrioventricular block. Am J Cardiol 1960; 6:153-177.
5. Packard JM, Graettinger JS, Graybiel A. Analysis of the electrocardiograms obtained from 1000 young healthy aviators; ten year follow-up. Circulation 1954; 10:384-400.
6. Perlman LV, Ostrander LD Jr, Keller JB, Chiang BN. An epidemiologic study of first degree atrioventricular block in Tecumseh, Michigan. Chest 1971; 59:40-46.
7. Rose G, Baxter PJ, Reid DD, McCartney P. Prevalence and prognosis of electrocardiographic findings in middle-aged men. Br Heart J 1978; 40:636-643.
8. Erikssen J, Otterstad JE. Natural course of a prolonged pr interval and the relation between pr and incidence of coronary heart disease. A 7-year follow-up study of 1832 apparently healthy men aged 40-59 years. Clin Cardiol 1984; 7:6-13.
9. Mymin D, Mathewson FA, Tate RB, Manfreda J. The natural history of primary first-degree atrioventricular heart block. N Engl J Med 1986; 315:1183-1187.
10. Cheng S, Keyes MJ, Larson MG, McCabe EL, Newton-Cheh C, Levy D, et al. Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block. JAMA 2009; 301:2571-2577.
11. Crisel RK, Farzaneh-Far R, Na B, Whooley MA. First-degree atrioventricular block is associated with heart failure and death in persons with stable coronary artery disease: data from the Heart and Soul Study. Eur Heart J 2011; 32:1875-1880.
12. Magnani JW, Wang N, Nelson KP, Connelly S, Deo R, Rodondi N, et al. Electrocardiographic PR interval and adverse outcomes in older adults: the Health, Aging, and Body Composition Study. Circ Arrhythm Electrophysiol 2013; 6:84-90.
13. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the Joint National Committee on Prevension, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. JAMA 2003; 289:2560-2572.
14. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949; 37:161-186.
15. Nieminen T, Verrier RL, Leino J, Nikus K, Lehtinen R, Lehtimaki T, et al. Atrioventricular conduction and cardiovascular mortality: assessment of recovery PR interval is superior to preexercise measurement. Heart Rhythm 2010; 7:796-801.
16. Barra SN, Providencia R, Paiva L, Nascimento J, Marques AL. A review on advanced atrioventricular block in young or middle-aged adults. Pacing Clin Electrophysiol 2012; 35:1395-1405.
17. Ginks W, Sutton R, Siddons H, Leatham A. Unsuspected coronary artery disease as cause of chronic atrioventricular block in middle age. Br Heart J 1980; 44:699-702.
18. Zoob M, Smith KS. The aetiology of complete heart-block. BMJ 1963; 2:1149-1153.
19. Fatkin D, MacRae C, Sasaki T, Wolff MR, Porcu M, Frenneaux M, et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 1999; 341:1715-1724.
20. Kandolin R, Lehtonen J, Kupari M. Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middleaged adults. Circ Arrhythm Electrophysiol 2011; 4:303-309.
21. Groh WJ, Groh MR, Saha C, Kincaid JC, Simmons Z, Ciafaloni E, et al. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med 2008; 358:2688-2697.
22. Schott JJ, Alshinawi C, Kyndt F, Probst V, Hoorntje TM, Hulsbeek M, et al. Cardiac conduction defects associate with mutations in SCN5A. Nat Genet 1999; 23:20-21.
23. Wang DW, Viswanathan PC, Balser JR, George AL Jr, Benson DW. Clinical, genetic, and biophysical characterization of SCN5A mutations associated with atrioventricular conduction block. Circulation 2002; 105:341-346.
24. Park HS, Kim YN, Lee YS, Jung BC, Lee SH, Shin DG, et al. Genetic analysis of SCN5A in Korean patients associated with atrioventricular conduction block. Genomics Inform 2012; 10:110-116.
25. Kudo M. A study of atrioventricular nodal function in patients with the sick sinus syndrome. Jpn Circ J 1979; 43:893-905.
26. Vallin H, Edhag O. Associated conduction disturbances in patients with symptomatic sinus node disease. Acta Med Scand 1981; 210:263-270.
27. Sakai Y, Imai S, Sato Y, Yagi H, Kushiro T. Clinical and electrophysiological characteristics of binodal disease. Circ J 2006; 70:1580-1584.
28. Dilaveris PE, Gialafos EJ, Sideris SK, Theopistou AM, Andrikopoulos GK, Kyriakidis M, et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 1998; 135:733-738.
29. Darbar D, Jahangir A, Hammill SC, Gersh BJ. P wave signal-averaged electrocardiography to identify risk for atrial fibrillation. Pacing Clin Electrophysiol 2002; 25:1447-1453.
30. Agarwal YK, Aronow WS, Levy JA, Spodick DH. Association of interatrial block with development of atrial fibrillation. Am J Cardiol 2003; 91:882.
31. Kim YH, O'Nunain S, Trouton T, Sosa-Suarez G, Levine RA, Garan H, Ruskin JN. Pseudo-pacemaker syndrome following inadvertent fast pathway ablation for atrioventricular nodal reentrant tachycardia. J Cardiovasc Electrophysiol 1993; 4:178-182.
32. Kruse I, Arnman K, Conradson TB, Ryden L. A comparison of the acute and long-term hemodynamic effects of ventricular inhibited and atrial synchronous ventricular inhibited pacing. Circulation 1982; 65:846-855.
33. Schoeller R, Andresen D, Buttner P, Oezcelik K, Vey G, Schroder R. First- or second-degree atrioventricular block as a risk factor in idiopathic dilated cardiomyopathy. Am J Cardiol 1993; 71:720-726.
34. Barold SS. Indications for permanent cardiac pacing in first-degree AV block: class I, II, or III? Pacing Clin Electrophysiol 1996; 19:747-751.
35. Eicher JC, Laurent G, Mathe A, Barthez O, Bertaux G, Philip JL, et al. Atrial dyssynchrony syndrome: an overlooked phenomenon and a potential cause of 'diastolic' heart failure. Eur J Heart Fail 2012; 14:248-258.
36. Blackburn H, Taylor HL, Keys A. Coronary heart disease in seven countries. XVI: the electrocardiogram in prediction of five-year coronary heart disease incidence among men aged forty through fiftynine. Circulation 1970; 41:I154-I161.
37. Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, White WB, et al. Principal results of the Controlled Onset Varepamil Investigation of Cardiovascular End points (CONVINCE) trial. JAMA 2003; 289:2073-2082.
38. Costanzo P, Perrone-Filardi P, Petretta M, Marciano C, Vassallo E, Gargiulo P, et al. Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175634 patients. J Hypertens 2009; 27:1136-1151.